Shanghai Labway Clinical Laboratory Co Ltd (301060) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.081x

Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has a cash flow conversion efficiency ratio of 0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥135.78 Million ≈ $19.87 Million USD) by net assets (CN¥1.67 Billion ≈ $244.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Labway Clinical Laboratory Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Labway Clinical Laboratory Co L total liabilities for a breakdown of total debt and financial obligations.

Shanghai Labway Clinical Laboratory Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
iQIYI Inc F:IQ8	-0.020x
Wecome Pharmaceutical Co Ltd SHE:300878	-0.001x
Contrel Technology Co Ltd TWO:8064	0.088x
ZJBC Information Technology Co Ltd SHE:000889	0.056x
Poly Union Chemical Holding Group Co Ltd SHE:002037	0.014x
Tipco Asphalt Public Company Limited F:NVP5	0.092x
Jiangxi Huawu Brake Co Ltd SHE:300095	0.034x
PWR Holdings Ltd AU:PWH	0.159x

Annual Cash Flow Conversion Efficiency for Shanghai Labway Clinical Laboratory Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Shanghai Labway Clinical Laboratory Co L stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.82 Billion ≈ $266.37 Million	CN¥216.31 Million ≈ $31.65 Million	0.119x	-56.98%
2023-12-31	CN¥1.98 Billion ≈ $289.76 Million	CN¥546.99 Million ≈ $80.04 Million	0.276x	+645.91%
2022-12-31	CN¥2.27 Billion ≈ $332.58 Million	CN¥84.17 Million ≈ $12.32 Million	0.037x	-72.83%
2021-12-31	CN¥1.64 Billion ≈ $239.96 Million	CN¥223.51 Million ≈ $32.71 Million	0.136x	+1.28%
2020-12-31	CN¥1.25 Billion ≈ $182.53 Million	CN¥167.87 Million ≈ $24.57 Million	0.135x	+131.24%
2019-12-31	CN¥1.21 Billion ≈ $177.52 Million	CN¥70.60 Million ≈ $10.33 Million	0.058x	-62.80%
2018-12-31	CN¥1.18 Billion ≈ $172.83 Million	CN¥184.79 Million ≈ $27.04 Million	0.156x	+280.90%
2017-12-31	CN¥1.10 Billion ≈ $161.60 Million	CN¥-95.52 Million ≈ $-13.98 Million	-0.086x	-295.93%
2016-12-31	CN¥614.70 Million ≈ $89.95 Million	CN¥27.14 Million ≈ $3.97 Million	0.044x	-83.09%
2015-12-31	CN¥305.25 Million ≈ $44.67 Million	CN¥79.70 Million ≈ $11.66 Million	0.261x	+163.44%
2014-12-31	CN¥201.13 Million ≈ $29.43 Million	CN¥-82.77 Million ≈ $-12.11 Million	-0.412x	-3402.03%
2013-12-31	CN¥130.79 Million ≈ $19.14 Million	CN¥1.63 Million ≈ $238.52K	0.012x	--

About Shanghai Labway Clinical Laboratory Co Ltd

SHE:301060 China Diagnostics & Research

Market Cap

$605.42 Million

CN¥4.14 Billion CNY

Market Cap Rank

#11561 Global

#3519 in China

Share Price

CN¥10.33

Change (1 day)

-1.81%

52-Week Range

CN¥9.06 - CN¥13.68

All Time High

CN¥52.42